摘要
目的:分析埃索美拉唑三联疗法根除幽门螺杆菌对于消化性溃疡的疗效。方法:收治幽门螺杆菌阳性消化性溃疡患者110例,随机分为对照组和观察组,各55例,对照组采取兰索拉唑三联疗法,观察组采取埃索美拉唑三联疗法,对比两组临床疗效。结果:观察组有效率95.55%明显高于对照组的81.82%(P<0.05),幽门螺杆菌根除率92.73%明显高于对照组的72.73%(P<0.05)。结论:采取埃索美拉唑三联疗法,幽门螺杆菌根除率提高,临床症状得到明显改善。
Objective:To explore the effect of esomeprazole triple therapy for eradicating helicobacter pylori on peptic ulcer. Methods:110 peptic ulcer patients with positive helicobacter pylori were selected.They were randomly divided into the control group and the observation group with 55 cases in each group.The control group was treated with lansoprazole triple therapy.The observation group was treated with esomeprazole triple therapy.We compared the clinical efficacy of two groups.Results:In the observation group the efficiency of 95.55% was significantly higher than 81.82% of the control group(P<0.05).Helicobacter pylori eradication rate of 92.73% was significantly higher than 72.73% in the control group(P<0.05).Conclusion:Taking esomeprazole triple therapy,helicobacter pylori eradication rate was increased.The clinical symptoms were significantly improved.
出处
《中国社区医师》
2015年第18期37-37,39,共2页
Chinese Community Doctors
关键词
埃索美拉唑
幽门螺杆菌
消化性溃疡
临床疗效
Esomeprazole
Helicobacter pylori
Peptic ulcer
Clinical curative effect
